HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe
Open accessAbstract
Europe is increasingly described as the region in the world with the least confidence in vaccination, and particularly in the safety of vaccines. The aim of this systematic literature review was to gather and summarise all peer-reviewed and grey literature published about determinants of Human Papillomavirus (HPV) vaccine hesitancy in Europe. Ten thematic categories were identified across the 103 articles which were included in the review. Participants from European studies most commonly reported issues with the quantity and quality of information available about HPV vaccination; followed by concerns about potential side effects of the vaccine; and mistrust of health authorities, healthcare workers, and new vaccines. Comparative analyses indicated that confidence determinants differed by country and population groups. This evidence supports the need to develop context-specific interventions to improve confidence in HPV vaccination and design community engagement strategies aiming to build public trust.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Low rates of vaccine compliance, particularly with the HPV vaccine, highlight challenges to overcoming potential vaccine hesitancy regarding SARS-CoV-2 vaccines in children.
“Low rates of vaccine compliance, particularly with the HPV vaccine,48 provide additional cautionary notes and highlight the challenges to be faced in overcoming potential vaccine hesitancy regarding SARS-CoV-2 vaccines in children.”
From SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,577 · see citing works
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works
Critical appraisal skills programme
Singh, J. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.107697 · Cited by 2,571 · see citing works
Larson, H. J., Jarrett, C., Eckersberger, E., Smith, D. M. D., & Paterson, P. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.081 · Cited by 2,254 · see citing works
Self-citationDubé, È., Laberge, C., Guay, M., Bramadat, P. A., Roy, R., & Bettinger, J. A. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.24657 · Cited by 2,178 · cited 1× · see citing works
“A number of studies have shown that uncertainty can influence as much as empirical evidence in vaccination decision-making.(122,123) Uncertainty is still often framed as something that can be overcome by filling information gaps with more facts; however, mistrust of health authorities and some doctors was commonly rep…”
BackgroundMethods for the synthesis of qualitative research: a critical review
Barnett-Page, E., & Thomas, J. (2009) · BMC Medical Research Methodology · doi:10.1186/1471-2288-9-59 · Cited by 2,087 · see citing works
RAMESES publication standards: realist syntheses
Wong, G., Greenhalgh, T., Westhorp, G., Buckingham, J., & Pawson, R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-21 · Cited by 1,374 · see citing works
The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey
Larson, H. J., de Figueiredo, A., Xiahong, Z., Schulz, W. S., Verger, P., Johnston, I. G., Cook, A. R., & Jones, N. S. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.042 · Cited by 1,264 · see citing works
Self-citationMeta‐synthesis method for qualitative research: a literature review
Walsh, D., & Downe, S. (2005) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2005.03380.x · Cited by 1,246 · see citing works
Strategies for addressing vaccine hesitancy–A systematic review
Jarrett, C., Wilson, R., O’Leary, M., Eckersberger, E., & Larson, H. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.040 · Cited by 1,066 · see citing works
Self-citationHow can systematic reviews incorporate qualitative research? A critical perspective
Dixon-Woods, M., Bonas, S., Booth, A., Jones, D. R., Miller, T., Sutton, A. J., Shaw, R. L., Smith, J. A., & Young, B. (2006) · Qualitative Research · doi:10.1177/1468794106058867 · Cited by 860 · see citing works
Bruni, L., Díaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 827 · cited 2× · see citing works
“Coverage rates have been suboptimal in some EU countries, particularly in Eastern Europe but also in Ireland, France, and Denmark.(2) Romania had initiated a programme in 2008, but discontinued their HPV vaccination in 2014, due to very low acceptance.”
BackgroundInfluentialCommunicating with parents about vaccination: a framework for health professionals
Leask, J., Kinnersley, P., Jackson, C., Cheater, F., Bedford, H. E., & Rowles, G. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-154 · Cited by 654 · see citing works
Strategies intended to address vaccine hesitancy: Review of published reviews
Dubé, È., Gagnon, D., & MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.041 · Cited by 649 · cited 2× · see citing works
“This fear was reported by 19% of hesitant HCWs in studies in France (2007–2015)22,74,107 and 23% of hesitant parents in studies in Italy (2007–2014).27,50,75 Concerns about girls being too young were reported by an average of 13% of hesitant study participants23,26,27,29,30,32,35,45,75 and 30% of general study partici…”
BackgroundRAMESES publication standards: meta-narrative reviews
Wong, G., Greenhalgh, T., Westhorp, G., Buckingham, J., & Pawson, R. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-20 · Cited by 610 · see citing works
RAMESES publication standards: realist syntheses
Wong, G., Greenhalgh, T., Westhorp, G., Buckingham, J., & Pawson, R. (2013) · Journal of Advanced Nursing · doi:10.1111/jan.12095 · Cited by 385 · see citing works
Karafillakis, E., & Larson, H. J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.061 · Cited by 301 · see citing works
Self-citationFuture acceptance of adolescent human papillomavirus vaccination: A survey of parental attitudes
Brabin, L., Roberts, S. A., Farzaneh, F., & Kitchener, H. C. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.048 · Cited by 283 · cited 2× · see citing works
“This fear was reported by 19% of hesitant HCWs in studies in France (2007–2015)22,74,107 and 23% of hesitant parents in studies in Italy (2007–2014).27,50,75 Concerns about girls being too young were reported by an average of 13% of hesitant study participants23,26,27,29,30,32,35,45,75 and 30% of general study partici…”
BackgroundParental attitudes to pre-pubertal HPV vaccination
Marlow, L. A. V., Waller, J., & Wardle, J. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.059 · Cited by 245 · see citing works
Understanding vaccination resistance: moving beyond risk
Hobson-West, P. (2003) · Health, Risk & Society · doi:10.1080/13698570310001606978 · Cited by 243 · cited 1× · see citing works
“A number of studies have shown that uncertainty can influence as much as empirical evidence in vaccination decision-making.(122,123) Uncertainty is still often framed as something that can be overcome by filling information gaps with more facts; however, mistrust of health authorities and some doctors was commonly rep…”
BackgroundBrabin, L., Roberts, S. A., Stretch, R., Baxter, D. N., Chambers, G., Kitchener, H. C., & McCann, R. (2008) · BMJ · doi:10.1136/bmj.39541.534109.be · Cited by 209 · cited 2× · see citing works
“The belief that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls was observed in an average of 11% of hesitant study participants.(22,23,26,32,50,71) This belief was also reported among 30% of general study participants(51,75,85,89,90,110,118) and 6% of favourable study participants.”
BackgroundGiuseppe, G. D., Abbate, R., Liguori, G., Albano, L., & Angelillo, I. F. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604454 · Cited by 189 · see citing works
Waller, J., Marlow, L. A. V., & Wardle, J. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0041 · Cited by 172 · cited 3× · see citing works
“Qualitative results Some participants in qualitative studies expressed a perceived lack of need for the HPV vaccine due to a perceived low risk of contracting HPV and/or cervical cancer,(55,59,66,80,100,109,115) a perceived low severity of the disease,(63,66,81) and/or the availability of alternative prevention method…”
BackgroundHendry, M., Lewis, R. A., Clements, A., Damery, S. L., & Wilkinson, C. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.091 · Cited by 154 · see citing works
Ethnic differences in human papillomavirus awareness and vaccine acceptability
Marlow, L. A. V., Wardle, J., Forster, A. S., & Waller, J. (2009) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.085886 · Cited by 153 · cited 2× · see citing works
“The belief that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls was observed in an average of 11% of hesitant study participants.(22,23,26,32,50,71) This belief was also reported among 30% of general study participants(51,75,85,89,90,110,118) and 6% of favourable study participants.”
BackgroundCrăciun, I. C., & Băban, A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.016 · Cited by 152 · cited 5× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundResultInfluentialWoodhall, S. C., Lehtinen, M., Verho, T., Huhtala, H., Hokkanen, M., & Kosunen, E. (2007) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2007.01.005 · Cited by 138 · see citing works
Trust and Experience as Predictors of HPV Vaccine Acceptance
Marlow, L. A. V., Waller, J., & Wardle, J. (2007) · Human Vaccines · doi:10.4161/hv.3.5.4310 · Cited by 138 · cited 1× · see citing works
“Mistrust of doctors was raised by 41% of hesitant parents in a 2009 study from the Netherlands,(26) and 45% of general parents and young adults in studies from Hungary (2009)(72) and the UK (2006).(91) Mistrust of new vaccines and concerns about the relative”
BackgroundBlödt, S., Holmberg, C., Müller‐Nordhorn, J., & Rieckmann, N. (2011) · European Journal of Public Health · doi:10.1093/eurpub/ckr188 · Cited by 132 · see citing works
McSherry, L. A., Dombrowski, S. U., Francis, J. J., Murphy, J., Martin, C. M., O’Leary, J. J., Sharp, L., & ATHENS Group (2012) · Implementation Science · doi:10.1186/1748-5908-7-73 · Cited by 129 · cited 4× · see citing works
“The high cost of the HPV vaccine was mentioned in five qualitative studies, from 2009–2010 in Sweden,64,102 2010–2014 in Bulgaria,98,104 2014 in the UK,98 2014 in Spain,98 and 2012 in Ireland.63 Another access barrier was the inconvenience of going to get multiple injections.67,115 The challenge of vaccinating in scho…”
BackgroundInfluentialPatel, H., Jeve, Y. B., Sherman, S. M., & Moss, E. L. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2015-052341 · Cited by 119 · see citing works
Arnheim‐Dahlström, L., Tran, T. N., Lundholm, C., Young, C., Sundström, K., & Sparén, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24712 · Cited by 116 · see citing works
Predictors of interest in HPV vaccination: A study of British adolescents
Marlow, L. A. V., Waller, J., Evans, R. E. C., & Wardle, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.057 · Cited by 113 · see citing works
Communication of risk: choice, consent, and trust
Calman, K. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09421-7 · Cited by 93 · see citing works
Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy
Napolitano, F., Napolitano, P., Liguori, G., & Angelillo, I. F. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1156271 · Cited by 90 · cited 1× · see citing works
“Quantitative results Concerns about the safety of HPV vaccination and potential long- or short-term side effects were reported by an average of 43% of hesitant study participants.(23-29,31,32,34-38,40,42,46,49,70-81) Fear of side effects was reported by an average of 52% of general study participants(51,82-97) and 17%…”
BackgroundSalad, J., Verdonk, P., de Boer, F., & Abma, T. (2015) · International Journal for Equity in Health · doi:10.1186/s12939-015-0198-3 · Cited by 87 · see citing works
Mortensen, G. L. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-68 · Cited by 85 · cited 2× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundGeneral practitioners’ attitudes and behaviors toward HPV vaccination: A French national survey
Collange, F., Fressard, L., Pulcini, C., Sebbah, R., Peretti‐Watel, P., & Verger, P. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.12.054 · Cited by 84 · cited 2× · see citing works
“This fear was reported by 19% of hesitant HCWs in studies in France (2007–2015)22,74,107 and 23% of hesitant parents in studies in Italy (2007–2014).27,50,75 Concerns about girls being too young were reported by an average of 13% of hesitant study participants23,26,27,29,30,32,35,45,75 and 30% of general study partici…”
BackgroundSelf-citationHaesebaert, J., Lutringer-Magnin, D., Kalecinski, J., Barone, G., Jacquard, A., Denois, V. R., Léocmach, Y., Vanhems, P., Chauvin, F., & Lasset, C. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-1034 · Cited by 83 · see citing works
Mortensen, G. L., Adam, M., & Idtaleb, L. (2015) · BMC Public Health · doi:10.1186/s12889-015-1863-6 · Cited by 76 · see citing works
Marek, E., Dergez, T., Rébék-Nagy, G., Kricskovics, A., Kovács, K., Bózsa, S., Kiss, I., Ember, I., & Göcze, P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.018 · Cited by 76 · see citing works
Pediatrician knowledge and attitudes regarding human papillomavirus disease and its prevention
Esposito, S., Bosis, S., Pelucchi, C., Begliatti, E., Rognoni, A., Bellasio, M., Tel, F., Consolo, S., & Principi, N. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.053 · Cited by 75 · see citing works
Grandahl, M., Oscarsson, M. G., Stenhammar, C., Nevéus, T., Westerling, R., & Tydén, T. (2013) · Acta Paediatrica · doi:10.1111/apa.12545 · Cited by 74 · cited 6× · see citing works
“Qualitative results Qualitative studies reported beliefs that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls(61,65-67,100,101,106,108,119) and that the vaccine could lead to unsafe sexual behaviour and a decrease in the use of condoms and cervical cancer screening.(55,57,63,64,66,67…”
BackgroundResultInfluentialBianco, A., Pileggi, C., Iozzo, F., Nobile, C. G. A., & Pavía, M. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.969614 · Cited by 73 · cited 3× · see citing works
“newness of the HPV vaccine was reported by an average of 36% of hesitant study participants.(22,27,45,74,75,107,111,112) In French studies, concerns about the newness of the vaccine,”
BackgroundDonders, G. G. G., Gabrovska, M., Bellen, G., Keirsbilck, J. V., den Bosch, T. V., Riphagen, I., & Verjans, M. (2007) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-007-0487-1 · Cited by 71 · see citing works
Simas, C., Muñóz, N., Arregocés-Castillo, L., & Larson, H. J. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1511667 · Cited by 71 · cited 1× · see citing works
“tion, which could prevent them from recommending the vaccine.(109,129) As HCWs are often considered the most trustworthy source of medical information,(130) it is important to address their own hesitancy, for instance by improving their training on the introduction of new vaccines.”
BackgroundSelf-citationHigh HPV vaccine acceptance despite low awareness among Swedish upper secondary school students
Gottvall, M., Larsson, M., Höglund, A. T., & Tydén, T. (2009) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625180903229605 · Cited by 70 · see citing works
Mupandawana, E. T., & Cross, R. (2016) · Reproductive Health · doi:10.1186/s12978-016-0209-x · Cited by 68 · cited 3× · see citing works
“Finally, conspiracy theories about the vaccine allegedly contributing to reducing world population or being an experiment on young girls were reported in studies in Bulgaria (2010–2013),(104) Romania (2010–2012),(52) Sweden (2014),(57) the Netherlands (2015),(65) and the UK (2007–2016).(59,100,105)”
BackgroundResultMass psychogenic response to human papillomavirus vaccination
Buttery, J. P., Madin, S., Crawford, N. W., Elia, S., Vincente, S. F. L., Hanieh, S., Smith, L. J., & Bolam, B. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02018.x · Cited by 65 · see citing works
Transparency in Europe: A Quantitative Study
Bouder, F. E., Balog‐Way, D. H. P., Löfstedt, R. E., & Evensen, D. T. N. (2015) · Risk Analysis · doi:10.1111/risa.12386 · Cited by 64 · see citing works
Immigrant women's experiences and views on the prevention of cervical cancer: a qualitative study
Grandahl, M., Tydén, T., Gottvall, M., Westerling, R., & Oscarsson, M. G. (2012) · Health Expectations · doi:10.1111/hex.12034 · Cited by 63 · cited 2× · see citing works
“In addition to worries about the duration of effectiveness of the vaccine, participants in qualitative studies also reported concerns that the vaccine did not protect against all types of HPV.(22,58,101,105,109,115,116) HUMAN VACCINES & IMMUNOTHERAPEUTICS 5”
BackgroundMedeiros, R., & Ramada, D. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.10.068 · Cited by 63 · cited 1× · see citing works
“administered, recent migration or not being in the target age group were also reported by an average 10% of hesitant participants in studies in the Netherlands (2009),(26) the UK (2011–2013),25,39 Italy (2008–2009),(121) Denmark (2009),(80) and Portugal (2007–2008).(33)”
BackgroundA survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
Brabin, L., Roberts, S. A., Stretch, R., Baxter, D. N., Elton, P., Kitchener, H. C., & McCann, R. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605362 · Cited by 63 · see citing works
Marlow, L. A. V., Wardle, J., & Waller, J. (2009) · Human Vaccines · doi:10.4161/hv.5.2.7368 · Cited by 60 · cited 3× · see citing works
“Qualitative results Some participants in qualitative studies expressed a perceived lack of need for the HPV vaccine due to a perceived low risk of contracting HPV and/or cervical cancer,(55,59,66,80,100,109,115) a perceived low severity of the disease,(63,66,81) and/or the availability of alternative prevention method…”
BackgroundHilton, S., & Smith, E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.03.101 · Cited by 58 · cited 2× · see citing works
“In addition to worries about the duration of effectiveness of the vaccine, participants in qualitative studies also reported concerns that the vaccine did not protect against all types of HPV.(22,58,101,105,109,115,116) HUMAN VACCINES & IMMUNOTHERAPEUTICS 5”
BackgroundSchool nurses' experiences of delivering the UK HPV vaccination programme in its first year
Hilton, S., Hunt, K., Bedford, H. E., & Petticrew, M. P. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-226 · Cited by 58 · cited 5× · see citing works
“Qualitative results A few qualitative studies reported that some participants were against all vaccines.(54,57,59,69,99,104) 6 E.”
BackgroundInfluentialBrabin, L., Roberts, S. A., & Kitchener, H. C. (2007) · BMC Public Health · doi:10.1186/1471-2458-7-20 · Cited by 56 · cited 1× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundParental Response to the Introduction of a Vaccine Against Human Papilloma Virus
Noakes, K., Yarwood, J., & SALISBURY, D. M. (2006) · Human Vaccines · doi:10.4161/hv.2.6.3391 · Cited by 54 · cited 3× · see citing works
“Qualitative results Some participants in qualitative studies expressed a perceived lack of need for the HPV vaccine due to a perceived low risk of contracting HPV and/or cervical cancer,(55,59,66,80,100,109,115) a perceived low severity of the disease,(63,66,81) and/or the availability of alternative prevention method…”
BackgroundMorison, L. A., Cozzolino, P. J., & Orbell, S. (2009) · British Journal of Health Psychology · doi:10.1348/135910709x437092 · Cited by 53 · cited 3× · see citing works
“In qualitative studies, the most commonly reported perceived side effect by parents was infertility.(52,57,59,60,65,100,102,106) Other perceived side effects included: autoimmune complications,(56,57,64,99,104,108) resistance of the virus to vaccines and/or treatment,(99,102,105) cancer,(52)menstrual complications,(65…”
BackgroundThe LYSISTRATA Study Group, Sotiriadis, A., Dagklis, T., Siamanta, V., Chatzigeorgiou, K., & Αγοραστός, Θ. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-2208-z · Cited by 51 · cited 2× · see citing works
“Concerns about side effects were particularly prevalent among hesitant participants from studies in the Netherlands (2009–2011, 69%),(26,28) Romania (2010, 60%),(79) and Greece (2005–2014, 54%).(31,34,40,42,78)”
BackgroundTrust versus concerns—how parents reason when they accept HPV vaccination for their young daughter
Gottvall, M., Grandahl, M., Höglund, A. T., Larsson, M., Stenhammar, C., Andrae, B., & Tydén, T. (2013) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2013.809039 · Cited by 49 · cited 1× · see citing works
“In Sweden, study participants in 2012 worried about the safety of HPV vaccination due to reports of narcolepsy following H1N1 vaccination.(56)”
BackgroundGefenaitė, G., Smit, M., Nijman, H. W., Tami, A., Drijfhout, I. H., Pascal, A., Postma, M. J., Wolters, B., van Delden, J. J. M., Wilschut, J., et al. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-498 · Cited by 49 · cited 6× · see citing works
“Quantitative results Across all studies, an average of 34% of hesitant participants were found to doubt the effectiveness of the vaccine, 75,77,114 as well as 39% of general participants(43,46,82,84-86,96) and 3% of favourable participants.(26,37) Perceived low vaccine effec-”
BackgroundResultInfluentialLutringer-Magnin, D., Kalecinski, J., Barone, G., Léocmach, Y., Denois, V. R., Jacquard, A. C., Soubeyrand, B., Vanhems, P., Chauvin, F., & Lasset, C. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.006 · Cited by 49 · cited 4× · see citing works
“newness of the HPV vaccine was reported by an average of 36% of hesitant study participants.(22,27,45,74,75,107,111,112) In French studies, concerns about the newness of the vaccine,”
BackgroundInfluentialStöcker, P., Dehnert, M., Schuster, M., Wichmann, O., & Deleré, Y. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22192 · Cited by 47 · see citing works
Parental attitudes and information needs in an adolescent HPV vaccination programme
Stretch, R., Roberts, S. A., McCann, R., Baxter, D. N., Chambers, G., Kitchener, H. C., & Brabin, L. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604766 · Cited by 47 · cited 4× · see citing works
“The belief that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls was observed in an average of 11% of hesitant study participants.(22,23,26,32,50,71) This belief was also reported among 30% of general study participants(51,75,85,89,90,110,118) and 6% of favourable study participants.”
BackgroundResultInfluentialPredictors of HPV vaccination uptake: a longitudinal study among parents
Hofman, R. M., van Empelen, P., Richardus, J. H., de Kok, I. M. C. M., de Koning, H. J., van Ballegooijen, M., & Korfage, I. J. (2013) · Health Education Research · doi:10.1093/her/cyt092 · Cited by 47 · see citing works
Gordon, D., Waller, J., & Marlow, L. A. V. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.083 · Cited by 45 · see citing works
Williams, K., Forster, A. S., Marlow, L. A. V., & Waller, J. (2011) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc.2010.0017 · Cited by 44 · cited 3× · see citing works
“Another access barrier was the inconvenience of going to get multiple injections.(67,115)”
BackgroundResultSundström, K., Tran, T. N., Lundholm, C., Young, C., Sparén, P., & Arnheim‐Dahlström, L. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.007 · Cited by 43 · see citing works
Stretch, R., McCann, R., Roberts, S. A., Elton, P., Baxter, D. N., & Brabin, L. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-254 · Cited by 43 · cited 1× · see citing works
“Additionally, some participants mentioned that the vaccine is being given to girls when they are too young because they have not started to menstruate, are not yet sexually active or married,(54,57,58,61,100,108) or because they are too “naïve and immature” to give their consent.(98,103) Some also reported that it is…”
BackgroundRemschmidt, C., Walter, D., Schmich, P., Wetzstein, M., Deleré, Y., & Wichmann, O. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.970920 · Cited by 41 · cited 2× · see citing works
“Quantitative results Across all studies, an average of 34% of hesitant participants were found to doubt the effectiveness of the vaccine, 75,77,114 as well as 39% of general participants(43,46,82,84-86,96) and 3% of favourable participants.(26,37) Perceived low vaccine effec-”
BackgroundResultPelullo, C. P., Giuseppe, G. D., & Angelillo, I. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042856 · Cited by 39 · cited 2× · see citing works
“Some also reported that it is not easy to talk about HPV vaccination with girls that are so young.(20,53,54,59,61,63,79,98,99,105,108,114) Finally, cultural and religious influences on vaccine acceptance reported in studies included perceived low risk of infec-”
BackgroundTozzi, A. E., Ravà, L., Stat, D., Pandolfi, E., Marino, M. G., & Ugazio, A. G. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.02.050 · Cited by 37 · cited 3× · see citing works
“The belief that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls was observed in an average of 11% of hesitant study participants.(22,23,26,32,50,71) This belief was also reported among 30% of general study participants(51,75,85,89,90,110,118) and 6% of favourable study participants.”
BackgroundExploring reasons for non-vaccination against human papillomavirus in Italy
VALORE, L. R. F., Giambi, C., D’Ancona, F. “., Manso, M. D., Mei, B. D., Giovannelli, I., Cattaneo, C., Possenti, V., & Declich, S. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0545-9 · Cited by 34 · cited 2× · see citing works
“newness of the HPV vaccine was reported by an average of 36% of hesitant study participants.(22,27,45,74,75,107,111,112) In French studies, concerns about the newness of the vaccine,”
BackgroundColes, V., Patel, A. S., Allen, F., Keeping, S. T., & Carroll, S. (2014) · International Journal of STD & AIDS · doi:10.1177/0956462414554629 · Cited by 34 · see citing works
Navarro‐Illana, P., Díez‐Domingo, J., Navarro-Illana, E., Tuells, J., Alemán, S., & Puig‐Barberà, J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-490 · Cited by 33 · see citing works
Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation
Firenze, A., Marsala, M. G. L., Bonanno, V., Maranto, M., Ferrara, C., Giovannelli, L., & Restivo, V. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.36158 · Cited by 32 · cited 2× · see citing works
“newness of the HPV vaccine was reported by an average of 36% of hesitant study participants.(22,27,45,74,75,107,111,112) In French studies, concerns about the newness of the vaccine,”
BackgroundMaier, C., Maier, T., Neagu, C., & Vlădăreanu, R. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.09.029 · Cited by 32 · cited 1× · see citing works
“Additionally, 11% of hesitant adolescent girls from a 2015 study from Romania reported that their parents thought the vaccine was unsafe.(30) An average of 75% of hesitant parents from a 2010 study from Romania(79) and 39% of hesitant young women from a 2013 study from Germany(37) reported being influenced by”
BackgroundKennedy, C. M., Brunton, C. G., & Hogg, R. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9356-4 · Cited by 31 · cited 2× · see citing works
“Additionally, some participants recommended providing information in schools, for instance by organising peer discussion groups with vaccinated girls(53,55-57,61,62,67,69); while others preferred social media or communication methods that allow more discretion.(52-54,62,69)”
BackgroundHofman, R., de Bekker-Grob, E. W., Raat, H., Helmerhorst, T. J. M., van Ballegooijen, M., & Korfage, I. J. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-454 · Cited by 30 · see citing works
Challenges and opportunities of a new HPV immunization program
Gottvall, M., Tydén, T., Larsson, M., Stenhammar, C., & Höglund, A. T. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.04.054 · Cited by 29 · see citing works
Understanding adolescents’ intentions to have the HPV vaccine
Forster, A. S., Marlow, L. A. V., Wardle, J., Stephenson, J., & Waller, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.11.082 · Cited by 29 · see citing works
Grandahl, M., Tydén, T., Rosenblad, A., Oscarsson, M. G., Nevéus, T., & Stenhammar, C. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-540 · Cited by 29 · cited 2× · see citing works
“monly reported by hesitant parents in a study in the Netherlands (2009, 52%)(26) and hesitant school nurses in a study in Sweden (2013, 48%).(110) The concern that it is too difficult to discussHPV vaccination with adolescent girls was also discussed in studies by an average of 21% of hesitant parents and paediatricia…”
BackgroundJackson, C., Dyson, L., Bedford, H. E., Cheater, F., Condon, L., Crocker, A., Emslie, C., Ireland, L., Kemsley, P., Kerr, S., et al. (2016) · Health Technology Assessment · doi:10.3310/hta20720 · Cited by 29 · see citing works
Working with vaccine-hesitant parents
MacDonald, N. E., Finlay, J. C., & Canadian Paediatric Society (2013) · Paediatrics & Child Health · doi:10.1093/pch/18.5.265 · Cited by 27 · see citing works
Parental attitudes towards vaccinating sons with human papillomavirus vaccine.
Mortensen, G. L. (2010) · PubMed · Cited by 27 · see citing works
Prue, G., Shapiro, G. K., Maybin, R., Santin, O., & Lawler, M. (2016) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2016.09.009 · Cited by 27 · see citing works
Giuliani, M., Vescio, M. F., Donà, M. G., Latini, A., Frasca, M., Colafigli, M., Farinella, M., Rezza, G., & Cristaudo, A. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1115935 · Cited by 26 · cited 1× · see citing works
“attended sexual health clinics reported receiving contradictory advice.(87) Some adolescents also reported being influenced by their parents, with 25% of hesitant adolescent girls from studies in the UK (2008–2013),(23,68) 39% of general adolescent girls from a study in Germany (2010)(95) and 1% of general adolescent…”
BackgroundYoung women’s decision-making process for HPV vaccination
Oscarsson, M. G., Hannerfors, A.-K., & Tydén, T. (2012) · Sexual & Reproductive Healthcare · doi:10.1016/j.srhc.2012.10.002 · Cited by 25 · cited 1× · see citing works
“In qualitative studies, the most commonly reported perceived side effect by parents was infertility.(52,57,59,60,65,100,102,106) Other perceived side effects included: autoimmune complications,(56,57,64,99,104,108) resistance of the virus to vaccines and/or treatment,(99,102,105) cancer,(52)menstrual complications,(65…”
BackgroundThe world must accept that the HPV vaccine is safe
Larson, H. J. (2015) · Nature · doi:10.1038/528009a · Cited by 25 · see citing works
Self-citationSadlier, C., Lynam, A., O’Dea, S., Delamere, S., Quinlan, M., Clarke, S., Sheils, O. M., & Bergin, C. J. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1151588 · Cited by 25 · cited 2× · see citing works
“In quantitative studies, cost was raised as an issue by an average of 32% of hesitant participants,31,38,74,75,80 particularly in studies in Denmark (2009, 62%)80 and Greece (2008–2014, 54%),31 and was also raised as a concern for an average of 47% of general study participants in Germany, Greece, Hungary, Ireland, an…”
BackgroundEstimated acceptance of HPV vaccination among Italian women aged 18–26 years
Giambi, C., Donati, S., Declich, S., Salmaso, S., Atti, M. L. C. D., Alibrandi, M. P., Brezzi, S., Carozzi, F., Collina, N., Franchi, D., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.079 · Cited by 24 · see citing works
Forster, A. S., Waller, J., Bowyer, H. L., & Marlow, L. A. V. (2015) · BMC Public Health · doi:10.1186/s12889-015-2657-6 · Cited by 24 · cited 5× · see citing works
“A perceived lack of need for the HPV vaccine was reported by an average of 14% of hesitant study participants,(25,31,32,36,38,70,75,121) 5% of general study participants,(88,95) and 2% of favourable study participants.(25) A perceived low risk of contracting HPV infection or developing cervical cancer was reported by…”
BackgroundInfluentialThe evaluation of an evidence-based clinical answer format for pediatricians
Seto, I., Foisy, M., Arkison, B., Klassen, T. P., & Williams, K. J. (2012) · BMC Pediatrics · doi:10.1186/1471-2431-12-34 · Cited by 22 · see citing works
Midwives at youth clinics attitude to HPV vaccination and their role in cervical cancer prevention
Oscarsson, M. G., Dahlberg, A., & Tydén, T. (2011) · Sexual & Reproductive Healthcare · doi:10.1016/j.srhc.2011.09.001 · Cited by 22 · cited 2× · see citing works
“Almost all qualitative articles described concerns about potential side effects of HPV vaccination,(52-57,59,60,62,64,66,69,98-107) often described as fears of long-term side effects not yet identified through trials.(54,55,59,60,62,64,66,69,81,98-104,106) In qualitative studies, the most commonly reported perceived s…”
BackgroundKaramanidou, C., & Dimopoulos, Κ. (2016) · BMC Public Health · doi:10.1186/s12889-016-2831-5 · Cited by 22 · cited 4× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundInfluentialHPV vaccination: vaccine acceptance, side effects and screening intentions.
Paul-Ebhohimhen, V., Huc, S., Tissington, H., Oates, K., & Stark, C. R. (2010) · PubMed · Cited by 21 · see citing works
Sabiani, L., Bremond, A. G., Mortier, I., Lécuyer, M., Boubli, L., & Carcopino, X. (2011) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2011.10.001 · Cited by 21 · see citing works
Working with vaccine-hesitant parents: An update
MacDonald, N. E., Desai, S. N., & Gerstein, B. (2018) · Paediatrics & Child Health · doi:10.1093/pch/pxy144 · Cited by 21 · see citing works
Sacks, R., Copas, A. J., Wilkinson, D., & Robinson, A. J. (2014) · Sexually Transmitted Infections · doi:10.1136/sextrans-2013-051179 · Cited by 20 · see citing works
Marek, E., Dergez, T., Kricskovics, A., Kovács, K., Rébék-Nagy, G., Gőcze, K., Kiss, I., Ember, I., & Göcze, P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.048 · Cited by 20 · see citing works
Korfage, I. J., Essink‐Bot, M., Daamen, R., Mols, F., & van Ballegooijen, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.03.018 · Cited by 19 · cited 1× · see citing works
“Concerns about girls being too young were reported by an average of 13% of hesitant study participants(23,26,27,29,30,32,35,45,75) and 30% of general study participants.(48,110) It was most com-”
BackgroundHPV vaccination acceptability in young boys.
Tisi, G., Salinaro, F., Apostoli, P., Bassani, R., Bellicini, A., Groppi, L., Donarini, P., & Pecorelli, S. (2013) · PubMed · doi:10.4415/ann_13_03_09 · Cited by 19 · see citing works
Parental Decisional Strategies Regarding HPV Vaccination Before Media Debates: A Focus Group Study
Hofman, R., van Empelen, P., Vogel, I., Raat, H., van Ballegooijen, M., & Korfage, I. J. (2013) · Journal of Health Communication · doi:10.1080/10810730.2012.757390 · Cited by 18 · cited 3× · see citing works
“In qualitative studies, the most commonly reported perceived side effect by parents was infertility.(52,57,59,60,65,100,102,106) Other perceived side effects included: autoimmune complications,(56,57,64,99,104,108) resistance of the virus to vaccines and/or treatment,(99,102,105) cancer,(52)menstrual complications,(65…”
BackgroundMammas, I., Theodoridou, M. N., Koutsaftiki, C., Bertsias, G. K., Sourvinos, G., & Spandidos, D. A. (2015) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.12.007 · Cited by 18 · cited 2× · see citing works
“Concerns about side effects were particularly prevalent among hesitant participants from studies in the Netherlands (2009–2011, 69%),(26,28) Romania (2010, 60%),(79) and Greece (2005–2014, 54%).(31,34,40,42,78)”
BackgroundMichail, G., Smaili, M., Vozikis, A., Jelastopulu, E., Adonakis, G. L., & Poulas, K. A. (2014) · Public Health · doi:10.1016/j.puhe.2014.09.005 · Cited by 17 · cited 1× · see citing works
“Concerns about side effects were particularly prevalent among hesitant participants from studies in the Netherlands (2009–2011, 69%),(26,28) Romania (2010, 60%),(79) and Greece (2005–2014, 54%).(31,34,40,42,78)”
BackgroundOpinions et pratiques des médecins généralistes face à la vaccination anti-Papillomavirus
Piana, L., Noel, G., Uters, M., Laporte, R., & Minodier, P. (2009) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2009.08.007 · Cited by 17 · see citing works
Rachiotis, G., Papagiannis, D., Symvoulakis, E. K., Daponte, A. I., Grivea, I. N., Syrogiannopoulos, G. A., & Hadjichristodoulou, C. S. (2013) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s49558 · Cited by 17 · cited 2× · see citing works
“Concerns about side effects were particularly prevalent among hesitant participants from studies in the Netherlands (2009–2011, 69%),(26,28) Romania (2010, 60%),(79) and Greece (2005–2014, 54%).(31,34,40,42,78)”
BackgroundLasset, C., Kalecinski, J., Denois, V. R., Barone, G., Léocmach, Y., Vanhems, P., Chauvin, F., & Lutringer-Magnin, D. (2014) · International Journal of Public Health · doi:10.1007/s00038-014-0555-9 · Cited by 17 · see citing works
Managing Uncertainty: Healthcare Professionals' Meanings Regarding the HPV Vaccine
Todorova, I. L. G., Alexandrova‐Karamanova, A., Panayotova, Y., Dimitrova, E., & Kotzeva, T. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9343-9 · Cited by 17 · cited 3× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundNavarro‐Illana, P., Caballero, P., Tuells, J., Puig‐Barberà, J., & Díez‐Domingo, J. (2015) · Anales de Pediatría · doi:10.1016/j.anpedi.2014.11.018 · Cited by 14 · see citing works
HPV vaccine acceptance among female Greek students
Bakogianni, G. D., Nikolakopoulos, K. M., & Nikoleta M Nikolakopoulou (2010) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh.2010.22.2.271 · Cited by 13 · cited 1× · see citing works
“Concerns about side effects were particularly prevalent among hesitant participants from studies in the Netherlands (2009–2011, 69%),(26,28) Romania (2010, 60%),(79) and Greece (2005–2014, 54%).(31,34,40,42,78)”
BackgroundD’Hauwers, K., Gadet, P. F. E., Donders, A. R. T., & Tjalma, W. A. A. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.09.068 · Cited by 13 · see citing works
Brunton, C. G., Farver-Vestergaard, I., Jaeger, M., Lenneis, A., Parve, K., Patarcic, D., Petrova, D., Hogg, R., Kennedy, C. M., García‐Retamero, R., et al. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-013-9357-3 · Cited by 12 · cited 4× · see citing works
“and perceptions that doctors were dismissive and deliberately withheld information about side effects.(52,65,98,104) Mistrust of pharmaceutical companies due to their underlying profitmaking motives and doubts about the trustworthiness of vaccine trials and safety claims were also reported in studies in Bulgaria (2009…”
BackgroundInfluentialPérez, R. O., Violeta, V. B., del Campo, A. V., Ruiz, C., Castaño, S. Y., Conde, L. P. P., & López, J. S. J. (2015) · Infectious Agents and Cancer · doi:10.1186/s13027-015-0034-9 · Cited by 12 · see citing works
Martinez, L., Tugaut, B., Raineri, F., Arnould, B., Seyler, D., Arnould, P., Benmedjahed, K., Coindard, G., Denis, F., Gallais, J.-L., et al. (2016) · Santé Publique · doi:10.3917/spub.161.0019 · Cited by 12 · cited 4× · see citing works
“Another access barrier was the inconvenience of going to get multiple injections.(67,115)”
BackgroundInfluentialSexual healthcare professionals’ views on HPV vaccination for men in the UK
Nadarzynski, T., Smith, H. E., Richardson, D., Ford, E. M., & Llewellyn, C. D. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.403 · Cited by 12 · see citing works
Pop, C. A. (2014) · Culture Health & Sexuality · doi:10.1080/13691058.2014.948491 · Cited by 10 · cited 1× · see citing works
“tion because of certain lifestyles (being virgins when marrying, having only one partner),(54,57,60,61,65,99,100,105,108,109) and having a strong sense of fatality and/or belief that God will protect girls.(113)”
BackgroundVacuna contra el virus del papiloma humano en adolescentes: Análisis mediante grupos focales
Puig, R. C., & Sanchis, M. M. (2015) · Revista de Salud Pública · doi:10.15446/rsap.v16n5.41021 · Cited by 9 · cited 2× · see citing works
“Qualitative results Healthcare professionals, including school nurses and GPs, were commonly referred to in qualitative studies as having the most influence on HPV vaccination decisions.(52,57,68,80,99,104,117) Additionally, the influence of family members, friends, and parents of other children who did not vaccinate…”
BackgroundPratiques et attitudes des médecins généralistes de Besançon vis-à-vis de la vaccination anti-HPV
Bouvret, P., Mougin, C., Prétet, J., Meurisse, A., Bonnetain, F., & Fiteni, F. (2016) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2015.12.002 · Cited by 9 · see citing works
Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)
Navarro‐Illana, P., Caballero, P., Tuells, J., Puig‐Barberà, J., & Díez‐Domingo, J. (2015) · Anales de Pediatría (English Edition) · doi:10.1016/j.anpede.2015.09.021 · Cited by 9 · see citing works
Perceptions of HPV vaccine amongst UK university students
Martin, E., Senior, N., Abdullah, A., Brown, J., Collings, S., Racktoo, S., Walpole, S. C., Zeiton, M. A., & Heffernan, C. (2011) · Health Education · doi:10.1108/09654281111180481 · Cited by 7 · cited 1× · see citing works
“Qualitative results Qualitative studies reported beliefs that HPV vaccination might encourage promiscuity or earlier sexual debut in young girls(61,65-67,100,101,106,108,119) and that the vaccine could lead to unsafe sexual behaviour and a decrease in the use of condoms and cervical cancer screening.(55,57,63,64,66,67…”
BackgroundLutringer-Magnin, D., Kalecinski, J., Barone, G., Borne, H., Denois, V. R., Vanhems, P., Chauvin, F., & Lasset, C. (2011) · Gynécologie Obstétrique & Fertilité · doi:10.1016/j.gyobfe.2011.07.015 · Cited by 6 · see citing works
van der Berg, J. D., Roorda, J., & Westerman, M. J. (2010) · PubMed · Cited by 5 · see citing works
Entscheidungsfindung zur HPV-Impfung – Eine qualitative Studie mit jugendlichen Mädchen
Klötzler, A., & Kolip, P. (2011) · Das Gesundheitswesen · doi:10.1055/s-0031-1286270 · Cited by 4 · cited 5× · see citing works
“Qualitative results A few qualitative studies reported that some participants were against all vaccines.(54,57,59,69,99,104) 6 E.”
BackgroundInfluentialAllaying parental concerns about the human papillomavirus vaccine
Hutton, S., & Finlay, F. (2009) · Nursing Children and Young People · doi:10.7748/paed2009.11.21.9.20.c7356 · Cited by 3 · see citing works
Hpv vaccination acceptance among women in Greek provincial areas
Βολτυράκη, Ε. Γ., Τσετσέκου, Ε., Marneras, C., Krapis, K., Yfantis, A., & Νούλα, Μ. (2010) · Cited by 3 · see citing works
Kuitto, K., Pickel, S., & Jahn, D. (2010) · Prävention und Gesundheitsförderung · doi:10.1007/s11553-010-0235-4 · Cited by 2 · see citing works
Parents' awareness and acceptance of HPV vaccination in Italy.
Baglioni, A. J., Ceriale, E., Bagnoli, A., Mercone, A., Nante, N., & Messina, G. (2014) · PubMed · Cited by 2 · see citing works
[Vaccination against papillomavirus: words of adolescents].
Fidalgo, C., Mauron, C., Nyffeler, S., Pache, B. C.-E., & Pereira, P. P. (2013) · PubMed · Cited by 2 · see citing works
[Posters at scientific congresses].
Steinert, T. (2012) · PubMed · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 132 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- [4]European Centre for Disease Prevention and Control Rapid literature review on motivating hesitant population groups in Europe to vaccinate. Stockholm, Sweden: ECDC; 2015.
- [11]SAGE Report of the SAGE working group on vaccine hesitancy. Geneva, Switzerland: WHO; 2014 10 Report No.
- [12]Pope C, Mays N, Jennie P Synthesising qualitative and quantitative health evidence: a guide to methods. Maidenhead, England: Open University Press; 2007.
- [68]Camano-Puig R, Sanchis-Martinez MM Human papilloma virus vaccination in teenage girls: a focus group evaluation. Revista de Salud Publica. 2014; 16: 646– 57. 26120751
- [79]Abram Z, Tar G Health education of mothers about their girls’ vaccination. 4th world conference on educational sciences. Procedia Soc Behav Sci. 2012; 462012: 5330– 34.
Cited by
Sorted by citations
Vaccine hesitancy in the era of COVID-19
Troiano, G., & Nardi, A. (2021) · Public Health · doi:10.1016/j.puhe.2021.02.025 · Cited by 1,342 · see citing works
Freeman, D. H., Loe, B. S., Chadwick, A., Vaccari, C., Waite, F., Rosebrock, L. E., Jenner, L., Petit, A., Lewandowsky, S., Vanderslott, S., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720005188 · Cited by 764 · see citing works
Larson, H. J., Gakidou, E. E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 516 · see citing works
Self-citationChew, N., Cheong, C., Kong, G., Phua, K., Ngiam, J. N., Tan, B. Y., Wang, B., Hao, F., Tan, W., Han, X., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.069 · Cited by 177 · see citing works
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies
Hussain, B., Latif, A., Timmons, S., Nkhoma, K. B., & Nellums, L. B. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.04.030 · Cited by 135 · see citing works
“Misconceptions about the immunisation process [45], lack of trust in government or healthcare [46], newness of a vaccine [47], perceived incompatibility of vaccines with religious and cultural beliefs [25] and conspiracy theories [48] were highlighted as factors known to aggravate lack of confidence in vaccines.”
López, N., Garcés‐Sánchez, M., Panizo, M. B., de la Cueva, I. S., Artés, M. T., Ramos, B., & Cotarelo, M. (2020) · Public health reviews · doi:10.1186/s40985-020-00126-5 · Cited by 122 · see citing works
“In terms of geographical distribution, publications included in this review were produced in 16 European countries, the UK having most publications, 20 (28.6%), followed by Italy, ten (14.3%), and Sweden, eight (11.4%).”
BackgroundInfluentialMultidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia
Wong, L.-P., Wong, P.-F., Hashim, M. M. A. A. M., Han, L.-Y., Lin, Y.-L., Hu, Z.-J., Zhao, Q.-J., & Zimet, G. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1756670 · Cited by 116 · see citing works
“sanctioning by families, and the creditability of traditional healers were also among the reasons that people in Asia prefer traditional remedies for cancer and vaccination.(17,57) The public should be warned against anecdotal evidence cautioned about the use of traditional medicines in the treatment and prevention of…”
BackgroundEuropean Groundshot—addressing Europe's cancer research challenges: a Lancet Oncology Commission
Lawler, M., Davies, L., Oberst, S., Oliver, K. R., Eggermont, A. M. M., Schmutz, A., Vecchia, C. L., Allemani, C., Lievens, Y. N., Naredi, P. L. J., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00540-x · Cited by 111 · see citing works
Wong, L. P., Wong, P., & AbuBakar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1706935 · Cited by 109 · see citing works
Sonawane, K., Zhu, Y., Montealegre, J. R., Lairson, D. R., Bauer, C., McGee, L. U., Giuliano, A. R., & Deshmukh, A. A. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30139-0 · Cited by 105 · see citing works
Sun, S., Lin, D., & Operario, D. (2020) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101350 · Cited by 106 · see citing works
“Mistrust of health authorities has shown to affect willingness for vaccination and vaccine trials of HPV and HIV, in Europe and United States (Strauss et al., 2001; Karafillakis et al., 2019).”
Sweileh, W. M. (2020) · BMC Public Health · doi:10.1186/s12889-020-09368-z · Cited by 83 · see citing works
Latkin, C. A., Dayton, L., Miller, J., Yi, G. T., Balaban, A., Boodram, B., Uzzi, M., & Falade-Nwulia, O. O. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2043102 · Cited by 81 · see citing works
Deshmukh, A. A., Damgacioglu, H., Georges, D., Sonawane, K., Ferlay, J., Bray, F., & Clifford, G. M. (2022) · International Journal of Cancer · doi:10.1002/ijc.34269 · Cited by 82 · see citing works
Childhood vaccination coverage in Europe: impact of different public health policies
Bechini, A., Boccalini, S., Ninci, A., Zanobini, P., Sartor, G., Bonaccorsi, G., Grazzini, M., & Bonanni, P. (2019) · Expert Review of Vaccines · doi:10.1080/14760584.2019.1639502 · Cited by 81 · see citing works
Wiyeh, A. B., Cooper, S., Jaca, A., Mavundza, E. J., Ndwandwe, D. E., & Wiysonge, C. S. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.09.019 · Cited by 79 · see citing works
Cadeddu, C., Castagna, C., Sapienza, M., Lanza, T. E., Messina, R., Chiavarini, M., Ricciardi, W., & de Waure, C. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1961466 · Cited by 79 · see citing works
“Actually, there has been an increase in papers on adolescents’vaccinations acceptance(5) but they mainly focused on vaccination against Human Papilloma Virus (HPV).(16,17) Nevertheless, depending on country-specific immunization programmes, vaccinations intended for adolescents also include those against hepatitis B,…”
BackgroundResultInfluentialMoore, J. X., Gilbert, K. L., Lively, K. L., Laurent, C., Chawla, R., Li, C., Johnson, R., Petcu, R., Mehra, M., Spooner, A., et al. (2021) · Vaccines · doi:10.3390/vaccines9080879 · Cited by 66 · see citing works
“Confidence is especially important when a vaccine is new [74].”
BackgroundChoi, Y., & FOX, A. M. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.115440 · Cited by 67 · see citing works
Martin, S., Kilich, E., Dada, S., Kummervold, P. E., Denny, C., Paterson, P., & Larson, H. J. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.072 · Cited by 66 · see citing works
Self-citationUnderstanding medical mistrust and HPV vaccine hesitancy among multiethnic parents in Los Angeles
Tsui, J., Martínez, B., Shin, M., Allee-Munoz, A., Rodriguez, I., Navarro, J., Thomas-Barrios, K. R., Kast, W. M., & Baezconde-Garbanati, L. A. (2022) · Journal of Behavioral Medicine · doi:10.1007/s10865-022-00283-9 · Cited by 60 · see citing works
Multi-perspectives systematic review on the applications of sentiment analysis for vaccine hesitancy
Alamoodi, A. H., Zaidan, B. B., Al-Masawa, M. E., Taresh, S. M., Noman, S., Ahmaro, I. Y. Y., Garfan, S., Chen, J., Ahmed, M. A., Zaidan, A. A., et al. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104957 · Cited by 61 · see citing works
“As for the health system factors, mistrust in the health care workers [17], governments [18], and/or health agencies [19] all contribute to the vaccine hesitancy phenomenon.”
Cooper, D. M., Afghani, B., Byington, C. L., Cunningham, C. K., Golub, S., Lu, K. D., Radom-Aizik, S., Ross, L. F., Singh, J., Smoyer, W. E., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01402-z · Cited by 55 · see citing works
Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications
Kolek, C. O., Opanga, S. A., Okalebo, F., Birichi, A. R., Kurdi, A. B., Godman, B., & Meyer, J. C. (2022) · Vaccines · doi:10.3390/vaccines10081185 · Cited by 55 · see citing works
Pavlovic, D., Sahoo, P., Larson, H. J., & Karafillakis, E. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2041360 · Cited by 53 · see citing works
Self-citationAdeyanju, G. C., Sprengholz, P., Betsch, C., & Essoh, T.-A. (2021) · Vaccines · doi:10.3390/vaccines9111231 · Cited by 51 · see citing works
Cervical Cancer and Human Papillomavirus Awareness among Women in Saudi Arabia
Akkour, K., Alghuson, L., Benabdelkamel, H., Alhalal, H., Alayed, N., AlQarni, A. A., & Arafah, M. (2021) · Medicina · doi:10.3390/medicina57121373 · Cited by 50 · see citing works
Vaccination against HPV: boosting coverage and tackling misinformation
Bigaard, J., & Franceschi, S. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12808 · Cited by 50 · see citing works
COVID-19 Vaccine Hesitancy: The Role of Information Sources and Beliefs in Dutch Adults
de Vries, H., Verputten, W., Preissner, C. E., & Kok, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063205 · Cited by 48 · see citing works
“Furthermore, a review on the human papillomavirus (HPV) vaccine identified ten thematic categories of VH determinants [17].”
BackgroundLuo, X., Zimet, G. D., & Shah, S. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1627821 · Cited by 48 · see citing works
“20 There are several limitations of the work reported here, which also serve as a cautionary tale for analysis of social media posts.”
BackgroundGriffin, B. L., Conner, M. T., & Norman, P. E. (2022) · Social Science & Medicine · doi:10.1016/j.socscimed.2022.114819 · Cited by 45 · see citing works
Rujumba, J., Akugizibwe, M., Basta, N. E., & Banura, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253735 · Cited by 44 · see citing works
“Undoubtedly, the provision of scientific information alone will not help reduce uncertainty and anxiety around HPV vaccination [51].”
BackgroundYu, V. G., Lasco, G., & David, C. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.07.051 · Cited by 44 · see citing works
Sackey, M. E., Markey, K., & Grealish, A. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.054 · Cited by 44 · see citing works
Heyde, S., Osmani, V., Schauberger, G., Cooney, C., & Klug, S. J. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03377-5 · Cited by 45 · see citing works
“%) are a major barrier to HPV vaccinations among parents in Europe [148].”
BackgroundDevelopment and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale
Kotta, I., Kálcza-Jánosi, K., Szabo, K., & Marschalkó, E. E. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.2007708 · Cited by 43 · see citing works
“Our results are in concordance with other findings, which highlighted the reaction of fear in COVID-19 vaccine delay decisions(26) and other vaccine uptake as well.(10,15,18) For rational health related decisions, strategies targeting the control of fear, skepticism and the attitude toward vaccine risks is advisable.”
BackgroundResultAltamimi, T. N. A. (2020) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_1205_19 · Cited by 41 · see citing works
“[10] There are many HPV‐related viruses or serotypes with the high‐risk HPV serotypes strongly correlated to cervical cancer.[11,12] Commonly observed high‐risk serotypes with oncogenic properties include HPV16 and 18.”
BackgroundHPV vaccine acceptance in West Africa: A systematic literature review
Wilson, R. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.06.074 · Cited by 41 · see citing works
Adeyanju, G. C., Betsch, C., Adamu, A. A., Gumbi, K. S., Head, M., Aplogan, A., Tall, H., & Essoh, T.-A. (2022) · Global Health Research and Policy · doi:10.1186/s41256-022-00261-3 · Cited by 43 · see citing works
“The guide comprised the following themes and topics, based on validated measures in the same setting [26, 27, 30]: knowledge of immunisation (“What do you know or think about immunisation?”); knowledge of HPV/cervical cancer (“Do you know or have you heard about cervical cancer and/or the HPV vaccine?”); attitude towa…”
BackgroundMethodChandeying, N., & Thongseiratch, T. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00912-w · Cited by 40 · see citing works
Knowledge and Attitudes on Vaccination in Southern Romanians: A Cross-Sectional Questionnaire
Popa, G., Muntean, A.-A., Muntean, M.-M., & Popa, M. (2020) · Vaccines · doi:10.3390/vaccines8040774 · Cited by 33 · see citing works
“Romania had initiated a program in 2008 but discontinued their HPV vaccination in 2014 due to a very low acceptance rate [18].”
Exploring enablers and barriers toward COVID-19 vaccine acceptance among Arabs: A qualitative study
Elbarazi, I., Yacoub, M. A., Reyad, O. A., Abdou, M. S. M., Elhadi, Y. A. M., Kheirallah, K. A., Ababneh, B. F., Hamada, B. A., Saeh, H. M. E., Ali, N., et al. (2022) · International Journal of Disaster Risk Reduction · doi:10.1016/j.ijdrr.2022.103304 · Cited by 38 · see citing works
The dynamics of trust and communication in COVID-19 vaccine decision making: A qualitative inquiry
Ledford, C. J. W., Cafferty, L. A., Moore, J. X., Roberts, C., Whisenant, E. B., Rychtarikova, A. G., & Seehusen, D. A. (2022) · Journal of Health Communication · doi:10.1080/10810730.2022.2028943 · Cited by 38 · see citing works
“Confidence is especially important when a vaccine is new (Karafillakis et al., 2019).”
BackgroundStages of HPV Vaccine Hesitancy Among Guardians of Female Secondary School Students in China
Zheng, W., Liu, Y., Zhang, L., Sun, X., Jiang, Q., Li, Z., Wu, Y., & Fu, C. (2022) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2022.08.027 · Cited by 37 · see citing works
“Similar phenomena have been found in Romania, the Netherlands, and Denmark [38].”
ResultAimagambetova, G. N., Babi, A., Issa, T., & Issanov, A. (2022) · Vaccines · doi:10.3390/vaccines10050824 · Cited by 37 · see citing works
“comparable with studies in European countries (Sweden, Hungary, France, and the UK), where mistrust of health authorities was reported by 47% to 55% of the respondents [46].”
BackgroundResultInfluentialLorini, C., Collini, F., Gasparini, F., Paolini, D., Grazzini, M., Ierardi, F., Galletti, G., Zanobini, P., Gemmi, F., & Bonaccorsi, G. (2020) · Vaccines · doi:10.3390/vaccines8020154 · Cited by 36 · see citing works
Gauna, F., Verger, P., Fressard, L., Jardin, M., Ward, J. K., & Peretti‐Watel, P. (2023) · BMC Public Health · doi:10.1186/s12889-023-15334-2 · Cited by 35 · see citing works
Self-citationAttitudes Toward HPV Vaccination in Sweden: A Survey Study
Wemrell, M., & Gunnarsson, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.729497 · Cited by 35 · see citing works
“A factor often found to influence decision-making is concerns for vaccine safety or side effects (10, 21, 38, 39, 42, 43, 46, 47, 49), which include references to the relative newness of the HPV vaccine (10, 46).”
BackgroundResultInfluentialNilsson, S., Mattsson, J. Y., Berghammer, M. C., Brorsson, A.-L., Forsner, M., Nolbris, M. J., Kull, I., Olinder, A. L., Ragnarsson, S., Rullander, A.-C., et al. (2021) · Vaccine X · doi:10.1016/j.jvacx.2021.100117 · Cited by 34 · see citing works
Jeannot, É., Viviano, M., Follonier, M.-C., Kaech, C., Oberhauser, N., Mpinga, E. K., Vassilakos, P., Kaiser, B., & Petignat, P. (2019) · Vaccines · doi:10.3390/vaccines7040130 · Cited by 33 · see citing works
Hviid, A. P., Thorsen, N. M., Valentiner‐Branth, P., Frisch, M., & Mølbak, K. (2020) · BMJ · doi:10.1136/bmj.m2930 · Cited by 32 · see citing works
Khosa, L. A., Meyer, J. C., Motshwane, F. M. M., Dochez, C., & Burnett, R. J. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.860809 · Cited by 32 · see citing works
Karafillakis, E., Peretti‐Watel, P., Verger, P., Chantler, T., & Larson, H. J. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.01.028 · Cited by 31 · see citing works
“The vaccine has also been described in this study and others as eliciting mistrust because of a perceived lack of scientific evidence around its safety and effectiveness [12,30].”
BackgroundResultSelf-citationAntonopoulou, V., Goffe, L., Meyer, C., Grimani, A., Graham, F., Lecouturier, J., Tang, M. Y., Chadwick, P., & Sniehotta, F. F. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2085461 · Cited by 31 · see citing works
Scott, V. K., Pinheiro, M. S. N., Machado, M. M. T., & Castro, M. C. (2023) · BMC Public Health · doi:10.1186/s12889-023-17005-8 · Cited by 30 · see citing works
“Vaccine hesitancy is often driven by concerns about safety and possible side effects, as seen in hesitancy surrounding HPV vaccines [42–44] and, more recently, COVID-19 vaccines [45, 46].”
BackgroundAchimaș-Cadariu, T., Paşca, A., Jiboc, N. M., Puia, A., & Dumitrascu, D. L. (2024) · Vaccines · doi:10.3390/vaccines12020127 · Cited by 30 · see citing works
Huon, J., Grégoire, A., Meireles, A. M., Lefebvre, M., Péré, M., Coutherut, J., Biron, C., Raffi, F., & Briend-Godet, V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234693 · Cited by 30 · see citing works
“In France, fear of the potential secondary effects is a predominant argument that is regularly cited [40].”
BackgroundChinawa, A. T., Chinawa, J. M., Ossai, E. N., Nduagubam, O. C., Onukwuli, V. O., Aronu, A. E., & Manyike, C. P. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1963172 · Cited by 29 · see citing works
Boucher, J.-C., Kim, S. Y., Jessiman‐Perreault, G., Edwards, J., Smith, H., Frenette, N., Badami, A., & Scott, L. A. (2023) · BMC Public Health · doi:10.1186/s12889-023-15615-w · Cited by 29 · see citing works
Optimising HPV vaccination communication to adolescents: A discrete choice experiment
Chyderiotis, S., Sicsic, J., Raude, J., Bonmarin, I., Jeanleboeuf, F., Banaszuk, A.-S., Gauchet, A., Bruel, S., Michel, M., Giraudeau, B., et al. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.05.061 · Cited by 28 · see citing works
The role of maturity in adolescent decision-making around HPV vaccination in France
Karafillakis, E., Peretti‐Watel, P., Verger, P., Chantler, T., & Larson, H. J. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.08.096 · Cited by 28 · see citing works
Self-citationWemrell, M., Vicente, R. P., & Merlo, J. (2022) · Scandinavian Journal of Public Health · doi:10.1177/14034948221075410 · Cited by 27 · see citing works
Petit, B., & Épaulard, O. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.049 · Cited by 26 · see citing works
COVID-19 vaccine delay: An examination of United States residents’ intention to delay vaccine uptake
Latkin, C. A., Dayton, L., Yi, G. T., Jaleel, A., Nwosu, C. C., & Limaye, R. J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1917234 · Cited by 24 · see citing works
Bocquier, A., Michel, M., Giraudeau, B., Bonnay, S., Gagneux‐Brunon, A., Gauchet, A., Gilberg, S., Duc-Banaszuk, A. S. L., Mueller, J. E., Chevreul, K., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-057943 · Cited by 25 · see citing works
Tjilos, M., Tamlyn, A. L., Ragan, E. J., Assoumou, S. A., Barnett, K. G., Martin, P., Perkins, R. B., Linas, B. P., & Drainoni, M. (2023) · BMC Public Health · doi:10.1186/s12889-023-15198-6 · Cited by 25 · see citing works
Cooper, S., Schmidt, B., Ryan, J., Leon, N., Mavundza, E. J., Burnett, R. J., Tanywe, A. C., & Wiysonge, C. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013430 · Cited by 24 · see citing works
Jin, J., & Han, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1462722 · Cited by 24 · see citing works
Human Papilloma Virus Vaccination: Focus on the Italian Situation
Gabutti, G., d’Anchera, E., Motoli, F. D., Savio, M., & Stefanati, A. (2021) · Vaccines · doi:10.3390/vaccines9121374 · Cited by 23 · see citing works
“A recent systematic review has identified the perceived low efficacy of the vaccine, possible side effects, lack of trust in health authorities and inadequate and partial information as the main causes of vaccine hesitancy regarding HPV vaccination in Europe [43].”
BackgroundUnderstanding the societal factors of vaccine acceptance and hesitancy: evidence from Hong Kong
Lau, B. H. P., Yuen, S., Yue, R. P. H., & Grépin, K. A. (2022) · Public Health · doi:10.1016/j.puhe.2022.03.013 · Cited by 23 · see citing works
Iova, C. F., Bădău, D., Daina, M. D., Șuteu, C. L., & Daina, L. (2023) · Patient Preference and Adherence · doi:10.2147/ppa.s421875 · Cited by 23 · see citing works
“13,21 70% of young people aged between 15 and 26 participating in a recent study, had knowledge about HPV vaccination and the association with cervical cancer; the main sources of information reported were similar to those in our study: those from the school (53”
Boulley, G. E., Mandrik, O., Préau, M., Herrero, R., & Villain, P. (2020) · Preventive Medicine · doi:10.1016/j.ypmed.2020.106323 · Cited by 23 · see citing works
Robles, C., Bruni, L., Acera, A., Riera, J. C., Prats, L., Poljak, M., Mlakar, J., Oštrbenk, A., Eriksson, T., Lehtinen, M., et al. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.08.032 · Cited by 23 · see citing works
“This is consistent with the qualitative findings in a European systematic review where men and women of all ages were asked about HPV vaccine for adults and children.(39) Therefore, to achieve high acceptance rates of the HPV vaccine, irrespective of the targeted age groups of the programs, it is important to involve…”
ResultJiboc, N. M., Paşca, A., Tăut, D., & Băban, A. (2023) · Psycho-Oncology · doi:10.1002/pon.6242 · Cited by 22 · see citing works
“The most common reasons for vaccination hesitancy were fear of side effects, worrying about the new vaccine, beliefs, and lack of information regarding the vaccine, 22 and religion.”
BackgroundShahbari, N. A. E., Gesser‐Edelsburg, A., Davidovitch, N., Brammli‐Greenberg, S., Grifat, R., & Mesch, G. S. (2021) · International Journal for Equity in Health · doi:10.1186/s12939-021-01523-1 · Cited by 22 · see citing works
Ryan, G. W., Avdic, L., Daly, E., Askelson, N. M., Farris, P. E., Shannon, J., McRee, A., Hanson, J. D., Kenyon, D. B., & Seegmiller, L. E. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1839290 · Cited by 21 · see citing works
Brohman, I., Blank, G., Mitchell, H., Dubé, È., & Bettinger, J. A. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2326779 · Cited by 21 · see citing works
“37 39 It is thus crucial from both a humanitarian and public health perspective to reduce vaccine-related anxiety.”
BackgroundMcKinley, C. J., Olivier, E., & Ward, J. K. (2023) · Vaccines · doi:10.3390/vaccines11081319 · Cited by 20 · see citing works
“A systematic review of 25 European countries—including France—showed that trust in health authorities was a central determinant of HPV vaccine hesitancy [32].”
BackgroundMarshall, S., Fleming, A., Sahm, L. J., & Moore, A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.01.025 · Cited by 20 · see citing works
Sabat, I., Neumann‐Böhme, S., Barros, P. P., Torbica, A., van Exel, J. N. A., Brouwer, W. B. F., Stargardt, T., & Schreyögg, J. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.07.017 · Cited by 20 · see citing works
Okunowo, A. A., Ugwu, A. O., Kuku, J. O., Soibi-Harry, A. P., Okunowo, B. O., Ani-Ugwu, N. K., Osunwusi, B. O., & Adenekan, M. A. (2021) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2021.101643 · Cited by 19 · see citing works
Impact of COVID-19 pandemic and vaccine perceptions on HPV vaccine hesitancy
Schelbar, N., Ward, C. N., Phillips, E. M., Herr, M. J., Acevedo, S., Conner, H., Greiner, A. K., & Corriveau, E. A. (2023) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2023.104172 · Cited by 19 · see citing works
Rivera, A. F., Dussault, J. M., Doglioni, D. O., Chyderiotis, S., Sicsic, J., Barret, A., Raude, J., Gauchet, A., Gagneux‐Brunon, A., Bruel, S., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2381300 · Cited by 19 · see citing works
“11,17,21,22 Consequently, young girls and women from underprivileged backgrounds have an increased risk of not benefiting from either of the two cervical cancer prevention measures throughout their lifetime.”
BackgroundHviid, A. P., & Thiesson, E. M. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.20391 · Cited by 18 · see citing works
Bennett, C. L., Edwards, D. J., Sherman, S., Baker, P., Waheed, D.-E.-N., Vorsters, A., Çevik, H. S., Karafillakis, E., Prue, G., & Kelly, D. M. (2022) · Sexually Transmitted Infections · doi:10.1136/sextrans-2022-055504 · Cited by 18 · see citing works
“After removal of duplicates, initial screening and eligibility assessment, 10 systematic reviews were considered suitable for inclusion.”
Self-citationBocquier, A., Bruel, S., Michel, M., Duc-Banaszuk, A.-S. L., Bonnay, S., Branchereau, M., Chevreul, K., Chyderiotis, S., Gauchet, A., Giraudeau, B., et al. (2023) · Health Expectations · doi:10.1111/hex.13778 · Cited by 18 · see citing works
Changes in general and COVID-19 vaccine hesitancy among U.S. adults from 2021 to 2022
Nguyen, K. H., Chung, L., McChesney, C., Vasudevan, L., Allen, J. D., & Bednarczyk, R. A. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2357230 · Cited by 18 · see citing works
Gauna, F., Raude, J., Khouri, C., Cracowski, J., & Ward, J. K. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2471225 · Cited by 17 · see citing works
Factors affecting children’s HPV vaccination in Austria: Evidence from a parent survey
Waser, M., Heiss, R., & Borena, W. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2126251 · Cited by 17 · see citing works
“rejection, followed by concerns about the vaccine’s safety voiced via concerns about a fear of side effects.(46) The primary reasons for rejecting HPV vaccination (i.”
BackgroundResultInfluentialCameron, R. L., Palmer, T. J., Cuschieri, K. S., Kavanagh, K., & Roy, K. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126177 · Cited by 17 · see citing works
Fakonti, G., Hadjikou, A., Tzira, E., Kyprianidou, M., & Giannakou, K. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.951039 · Cited by 17 · see citing works
Parental Factors Affecting Decision to Vaccinate Their Daughters against Human Papillomavirus
Park, Y., Ki, M., Lee, H., Lee, J. K., & Oh, J. (2023) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0412 · Cited by 16 · see citing works
Alarcão, V., & Zdravkova, B. (2022) · Societies · doi:10.3390/soc12050131 · Cited by 16 · see citing works
“HPV vaccination coverage rates are affected by social norms (including of one’s family, friends, healthcare professionals, and religious or community leaders) [10].”
BackgroundInfluentialCooper, S., Schmidt, B., Jama, N. A., Ryan, J., Leon, N., Mavundza, E. J., Burnett, R. J., Tanywe, A. C., & Wiysonge, C. S. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013430.pub2 · Cited by 15 · see citing works
Henschke, N., Bergman, H., Buckley, B. S., Crosbie, E. J., Dwan, K. M., Golder, S., Kyrgiou, M., Loke, Y. K., McIntosh, H. M., Probyn, K., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015363.pub2 · Cited by 17 · see citing works
The Effectiveness of Interventions Targeting Adolescents in HPV Vaccination—A Scoping Review
Iova, C. F., Daina, L., Daina, M. D., & Ghitea, T. C. (2024) · Medicina · doi:10.3390/medicina60091550 · Cited by 15 · see citing works
“Distrust of vaccines in general, concerns about vaccine efficacy [57], doubts about the benefits of vaccines, and low perception of disease risk and disease severity are important barriers to vaccination [51,52].”
BackgroundInfluentialLin, X., Zhang, M., Chen, Y., Xue, J.-J., Chen, H.-D., Tung, T., & Zhu, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.770933 · Cited by 15 · see citing works
“In addition, compared with hesitation for other vaccines (18, 19), there was a higher proportion of hesitation for the COVID-19 vaccine, suggesting that the Chinese population still has a certain degree of nervousness about the COVID-19 vaccine.”
BackgroundProkopovich, K., Phillipson, L., West, L., Stanoevska, B., Street, J., & Braunack‐Mayer, A. (2023) · Health Expectations · doi:10.1111/hex.13703 · Cited by 15 · see citing works
Dib, F., Mayaud, P., Renaudie, C., Launay, O., & Chauvin, P. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2083894 · Cited by 14 · see citing works
Self-citationWarsi, S. K., Nielsen, S. M., Franklin, B. A. K., Abdullaev, S., Ruzmetova, D., Raimjanov, R., Nagiyeva, K., & Safaeva, K. (2023) · Vaccines · doi:10.3390/vaccines11040754 · Cited by 14 · see citing works
- Authors
- Karafillakis, E., Simas, C., Jarrett, C., Verger, P., Peretti-Watel, P., Dib, F., De Angelis, S., Takacs, J., Ali, K. A., Pastore Celentano, L., & Larson, H.
- Affiliations
- London School of Hygiene & Tropical Medicine (GB)
- Swiss Tropical and Public Health Institute (CH)
- Inserm (FR)
- Aix Marseille Univ, IRD, AP-HM, SSA, VITROME, IHU-Méditerranée Infection, Marseille, France
- Vaccine Preventable Disease Programme, European Centre for Disease Prevention and Control, Stockholm, Sweden
- Centre for Social Sciences, Hungarian Academy of Sciences, Budapest, Hungary
- European Centre for Disease Prevention and Control (SE)
- University of Washington (US)
- Corresponding author
- Karafillakis, Emilie
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2019-02-20
- Volume
- 15
- Issue
- 7-8
- Pages
- 1615-1627
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- PMC
- PMC6783136
- OpenAlex
- W2910348912
- Cited by
- 328
- References
- 132
- Citations by year
- 2026: 43 · 2025: 53 · 2024: 49 · 2023: 48 · 2022: 63 · 2021: 36 · 2020: 25 · 2019: 11
- FWCI
- 7.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Human Vaccines & Immunotherapeutics (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- edoc (University of Basel) (acceptedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- HAL AMU (submittedVersion, cc-by-nc-nd)
- Funders
- European Centre for Disease Prevention and Control (OCS-2016-0UT-2050-MCTeFo)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- HPV vaccination, vaccine hesitancy, vaccine confidence, vaccine safety concerns, vaccine side effects, determinants of vaccine hesitancy, community participation, Europe
- MeSH terms
- Vaccination Refusal, Uterine Cervical Neoplasms, Europe, Female, Humans, Health Knowledge, Attitudes, Practice, Patient Acceptance of Health Care, Vaccination, Papillomavirus Infections, Uncertainty, Trust, Papillomavirus Vaccines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review